Antioxidant intervention blunts renal injury in experimental renovascular disease.
about
Hypoxia: The Force that Drives Chronic Kidney DiseaseParadigm Shifts in Atherosclerotic Renovascular Disease: Where Are We Now?Gained in translation: protective paradigms for the poststenotic kidneyIntravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapyChronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?Antioxidants improve early survival of cardiomyoblasts after transplantation to the myocardium.Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate.Simvastatin decreases endothelial progenitor cell apoptosis in the kidney of hypertensive hypercholesterolemic pigsRole of renal microcirculation in experimental renovascular disease.Early atherosclerosis aggravates the effect of renal artery stenosis on the swine kidney.Mitochondrial protection restores renal function in swine atherosclerotic renovascular disease.Early experimental hypertension preserves the myocardial microvasculature but aggravates cardiac injury distal to chronic coronary artery obstruction.Berberine ameliorates chronic kidney injury caused by atherosclerotic renovascular disease through the suppression of NFκB signaling pathway in rats.Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?Revascularization of swine renal artery stenosis improves renal function but not the changes in vascular structure.Improved survival of mesenchymal stromal cell after hypoxia preconditioning: role of oxidative stress.Persistent kidney dysfunction in swine renal artery stenosis correlates with outer cortical microvascular remodeling.Role of oxidative stress in hypoxia preconditioning of cells transplanted to the myocardium: a molecular imaging study.Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines.Experimental coronary artery stenosis accelerates kidney damage in renovascular hypertensive swine.Atherosclerotic renal artery stenosis: current statusIncreased glomerular filtration rate in early metabolic syndrome is associated with renal adiposity and microvascular proliferationIntra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease.Reversal of experimental renovascular hypertension restores coronary microvascular function and architecturePositive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric DogsInflammatory and injury signals released from the post-stenotic human kidneyChanges in glomerular filtration rate after renal revascularization correlate with microvascular hemodynamics and inflammation in Swine renal artery stenosisChronic renovascular hypertension is associated with elevated levels of neutrophil gelatinase-associated lipocalin.Early atherosclerosis aggravates renal microvascular loss and fibrosis in swine renal artery stenosis.Hypercholesterolemia Impairs Nonstenotic Kidney Outcomes After Reversal of Experimental Renovascular HypertensionObesity-metabolic derangement preserves hemodynamics but promotes intrarenal adiposity and macrophage infiltration in swine renovascular disease.Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.Redox signaling is an early event in the pathogenesis of renovascular hypertension.Endothelial progenitor cells restore renal function in chronic experimental renovascular disease.Angiogenesis in the kidney: a new therapeutic target?Sildenafil ameliorates oxidative stress and DNA damage in the stenotic kidneys in mice with renovascular hypertension.Renal vascular structure and rarefaction.Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond.Disparate effects of single endothelin-A and -B receptor blocker therapy on the progression of renal injury in advanced renovascular diseaseThe Effects of Long-Term Chaetomellic Acid A Administration on Renal Function and Oxidative Stress in a Rat Model of Renal Mass Reduction.
P2860
Q26768865-92EC6130-7263-455E-A168-A98EDF437447Q26828388-425ED835-D7EE-4DD5-8FE6-9F19F76DB04AQ27011613-110D9FF7-0282-4B0C-B26A-4770404229AAQ27027097-22FE0680-92B9-4DB3-A215-E70B93A03799Q28085141-7AE9BE5E-6E61-4B69-8D3D-1B99029E7225Q30475341-960118EB-2A23-4AEE-85EF-FB240BD9E4C6Q33566245-92BA9850-3D56-4C13-ACD6-0E2DA635337BQ33835733-56C79CF2-EDB6-4800-9D99-FD3F68319A30Q33988621-4DEFF822-7D94-417B-BD65-CE21C12F920AQ33995109-E429357F-1DCE-461F-8882-DA27E5237C12Q34137989-D2750D37-7953-45F9-A194-B9F30B3F4DB3Q34600253-FBE17390-3995-4052-94C6-4821CB41F413Q34652245-D354085E-8FFD-48B9-9FC7-52AB3E0C1DA8Q34704572-D23A7DDB-558E-43F6-A060-B49E79FEE0DBQ34706252-03C90ECB-5B20-4E39-98CE-B9F2804FB5A9Q34753654-64DD90D3-8DB5-441D-A08A-0FF829EC637CQ35057138-4E86EB5C-5EC2-444C-A37C-8C8EFE459206Q35135124-80FAFB8A-36D6-4C37-9CEF-69AABFB7F47DQ35239892-6A3D0FD8-303D-41CD-A5A9-AE8AAB21EE01Q35243364-BCA920A8-DE3D-4C4B-A87B-25BB7492E18DQ35537676-B50D5487-DBE0-4F70-95CC-356BCC1E2D0AQ35543224-BE86F355-8557-4A43-B059-019BADA7AE97Q35562620-76D5B98F-4763-44EF-9BBD-099212BC0D96Q35628592-096D2E55-7224-4999-A57F-C3211D6CD0B4Q35992197-46482337-45B3-416F-B9A6-6FD8A1B7F219Q36609944-D05F2164-A37A-4D02-A063-23C9219D3921Q36713809-81E35A50-AF1D-40C6-A089-EB24534B4AF9Q36740975-1C9B4ECF-66A4-42AB-8D40-81A922C66118Q36791992-5DCC71A6-0988-4344-B1B2-2576A3B0E72AQ36991756-FEA6AF91-CF83-48A5-8CEC-57A278BE5D13Q37093643-B4EF8E48-D9E9-4E4E-B4B4-001C8BA42816Q37174513-F224F617-B2EA-4326-99A7-D3CC4EBEB5CAQ37225203-67F396B9-285A-4337-AFF5-6F88121F68A0Q37377904-44604F2C-9027-423A-B37A-867963D9FAFBQ37476639-E14B46C8-83BC-4809-B595-B2374E239159Q37579514-7230A799-326B-4E10-B145-367AF109834CQ37605855-24F7D8BA-5299-4B62-96EE-8E8004C838A0Q37633670-046CEAC1-22C9-4F18-A7BB-0694F01ABC42Q37678657-82BEFA5F-85BD-4663-8862-7DB4E6C54F62Q37689808-F8FCEEB4-332A-40E9-8EE2-A9E70560234B
P2860
Antioxidant intervention blunts renal injury in experimental renovascular disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Antioxidant intervention blunts renal injury in experimental renovascular disease.
@en
Antioxidant intervention blunts renal injury in experimental renovascular disease.
@nl
type
label
Antioxidant intervention blunts renal injury in experimental renovascular disease.
@en
Antioxidant intervention blunts renal injury in experimental renovascular disease.
@nl
prefLabel
Antioxidant intervention blunts renal injury in experimental renovascular disease.
@en
Antioxidant intervention blunts renal injury in experimental renovascular disease.
@nl
P2093
P50
P1476
Antioxidant intervention blunts renal injury in experimental renovascular disease.
@en
P2093
Alejandro R Chade
Joerg Herrmann
Joseph P Grande
Martin Rodriguez-Porcel
Xiangyang Zhu
P304
P356
10.1097/01.ASN.0000117774.83396.E9
P577
2004-04-01T00:00:00Z